Skip to main content
Menu
Home
About us
Team
Companies
Stories
ESG
News
Keensight Connect
Contact
Close Search
Press Release
Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities
By
WeAreBlow
January 10, 2023
No Comments
Download
Previous Post
Valiantys sets strategy to strengthen its position in Europe by acquiring kreuzwerker's Atlassian consulting business, with the support of Keensight Capital
Next Post
Keensight Capital to acquire majority stake in Quanos
Close Menu
Home
About us
Team
Companies
Stories
ESG
News
Keensight Connect
Contact